Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
1440
mi
from 98109
Wichita, KA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
1440
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Boston Center for Memory
2479
mi
from 98109
Newton, MA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Boston Center for Memory
2479
mi
from 98109
Newton, MA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Professionals
1706
mi
from 98109
Chesterfield, MO
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Professionals
1706
mi
from 98109
Chesterfield, MO
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Millenium Psychiatric Associates LLC
1709
mi
from 98109
Creve Coeur, MO
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Millenium Psychiatric Associates LLC
1709
mi
from 98109
Creve Coeur, MO
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Las Vegas Medical Research
873
mi
from 98109
Las Vegas, NV
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Las Vegas Medical Research
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Memory Enhancement Center of America, Inc.
2412
mi
from 98109
Eatontown, NJ
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Memory Enhancement Center of America, Inc.
2412
mi
from 98109
Eatontown, NJ
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Advanced Memory Research Institute of New Jersey
2415
mi
from 98109
Toms River, NJ
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Advanced Memory Research Institute of New Jersey
2415
mi
from 98109
Toms River, NJ
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Bio Behavioral Health
2418
mi
from 98109
Toms River, NJ
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Bio Behavioral Health
2418
mi
from 98109
Toms River, NJ
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
2353
mi
from 98109
Albany, NY
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
2353
mi
from 98109
Albany, NY
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Dent Neurological Institute
2111
mi
from 98109
Amherst, NY
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Dent Neurological Institute
2111
mi
from 98109
Amherst, NY
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Insight Clinical Trials
2028
mi
from 98109
Shaker Heights, OH
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Insight Clinical Trials
2028
mi
from 98109
Shaker Heights, OH
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Lehigh Center for Clinical Research
2335
mi
from 98109
Allentown, PA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Lehigh Center for Clinical Research
2335
mi
from 98109
Allentown, PA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Center, LLC, Psychiatry
2370
mi
from 98109
Jenkintown, PA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Center, LLC, Psychiatry
2370
mi
from 98109
Jenkintown, PA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of South Carolina
2412
mi
from 98109
Charleston, SC
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of South Carolina
2412
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Nantz National Alzheimer Center
1890
mi
from 98109
Houston, TX
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Nantz National Alzheimer Center
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Services Center - Houston
1893
mi
from 98109
Houston, TX
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Services Center - Houston
1893
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from 98109
Box Hill,
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from 98109
Box Hill,
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Florida International Research Center
2732
mi
from 98109
Miami, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Florida International Research Center
2732
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Sensible Healthcare
2538
mi
from 98109
Ocoee, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Sensible Healthcare
2538
mi
from 98109
Ocoee, FL
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Fort Wayne Neurological Center
1874
mi
from 98109
Fort Wayne, IN
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Fort Wayne Neurological Center
1874
mi
from 98109
Fort Wayne, IN
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
2457
mi
from 98109
Jacksonville, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
2457
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
The Neurology Research Group, LLC
2730
mi
from 98109
Miami, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
The Neurology Research Group, LLC
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
ST. Luke's Hospital
1504
mi
from 98109
Kansas City, MO
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
ST. Luke's Hospital
1504
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
2370
mi
from 98109
Abington, PA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
2370
mi
from 98109
Abington, PA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
North Bay Neuroscience Institute
574
mi
from 98109
Sebastopol, CA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
North Bay Neuroscience Institute
574
mi
from 98109
Sebastopol, CA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Compass Research
2603
mi
from 98109
Melbourne, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Compass Research
2603
mi
from 98109
Melbourne, FL
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Valley Medical Primary Care
1965
mi
from 98109
Centerville, OH
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Valley Medical Primary Care
1965
mi
from 98109
Centerville, OH
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Ray Dolby Brain Health Center/Sutter Health/CPMC
681
mi
from 98109
San Francisco, CA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Ray Dolby Brain Health Center/Sutter Health/CPMC
681
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Syrentis Clinical Research
987
mi
from 98109
Santa Ana, CA
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Syrentis Clinical Research
987
mi
from 98109
Santa Ana, CA
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
New England Institute for Clinical Research
2411
mi
from 98109
Stamford, CT
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
New England Institute for Clinical Research
2411
mi
from 98109
Stamford, CT
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Neurology Diagnostics, Inc
1959
mi
from 98109
Dayton, OH
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Neurology Diagnostics, Inc
1959
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Baylor AT&T Memory Center
1678
mi
from 98109
Dallas, TX
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Baylor AT&T Memory Center
1678
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Pyramid Clinical Research
2378
mi
from 98109
Monroe, NJ
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Pyramid Clinical Research
2378
mi
from 98109
Monroe, NJ
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Missouri Memory Center
1612
mi
from 98109
Bolivar, MO
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Missouri Memory Center
1612
mi
from 98109
Bolivar, MO
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati Health Neurology
1966
mi
from 98109
Dayton, OH
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Health Neurology
1966
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated:  12/31/1969
Meridien Research
2500
mi
from 98109
Spring Hill, FL
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Status: Enrolling
Updated: 12/31/1969
Meridien Research
2500
mi
from 98109
Spring Hill, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1101
mi
from 98109
Sun City, AZ
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1101
mi
from 98109
Sun City, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
971
mi
from 98109
Downey, CA
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
971
mi
from 98109
Downey, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1049
mi
from 98109
La Jolla, CA
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1049
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
994
mi
from 98109
Newport Beach, CA
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
994
mi
from 98109
Newport Beach, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2322
mi
from 98109
Washington,
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2693
mi
from 98109
Delray Beach, FL
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2693
mi
from 98109
Delray Beach, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2616
mi
from 98109
Fort Myers, FL
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2616
mi
from 98109
Fort Myers, FL
Click here to add this to my saved trials